Get started
NATCO PHARMA LTD.NATCO PHARMA LTD.NATCO PHARMA LTD.

NATCO PHARMA LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

NATCOPHARM trade ideas

Perfect Time for a Long Entry.Natco Pharma has clearly turned it's way now, after a fall of more than 20% from it's ATH, is has shown some good reversal confirmations, first being it has take rejection form Fibonacci 0.5 level as well as From it's Important Support Zone, Second being formation of two Bullish Chart Pattern i.e. Inverted Head & Shoulders and Falling Wedge pattern and it has given breakout of these pattern too. There are higher probabilities of it going towards a New ATH.
NSE:NATCOPHARMLong
by Trading_Mentor_Amaan
2
simple pattern based tradeAfter correcting a fair bit from its recently made all time highs my favourite pharma stock has been going in a zig zag manner while fundamentally it recently sold certain non core assets for some 150 odd crores... so whats cooking, will it announce the first of its long awaited brownfield acquisitons? Anyhow, it has formed a symmetrical triangle and the same should cleanly breakout between 10th and 17th dec, both dates included... target is near to its ATH of 1636... Although I may hold upto 17th dec as long as the price remains within the triangle, it is prudent to keep SL of 1400 on daily closing basis...
NSE:NATCOPHARMLong
by Rocky_Chow
Natco Pharma for 45%+ gainsDate: 21 Nov’24 Symbol: NATCOPHARM Timeframe: Daily Natco Pharma currently seems to be in Wave IV of 3 which could end around 1240-1220 and Wave V could then head towards 1800-1900 levels (45%+ from where Wave IV would end) as seen in the chart. A more precise target can be pinned once it makes a fresh ATH. Two levels (1770 & 1900) have been marked as possible supply zone. The company recently posted good Q2 numbers. The stock is currently trading at a PE multiple of 12.6 while the industry average is around 32. This is not a prediction but a possible wave count. This is also not a recommendation to trade or invest. Please do your own analysis. HINGLISH VERSION Natco Pharma vartamaan mein 3 ke Wave IV mein hai, jo 1240-1220 ke aaspaas samaapt ho sakta hai aur Wave V phir 1800-1900 ke star (45%+ jahaan Wave IV samaapt hoga) kee taraf badh sakta hai, jaisa ki chart mein dekh sakte hain. Ek baar naya ATH banaane par adhik sateek target pin kiya ja sakta hai. Do staron (1770 aur 1900) ko sambhaavit supply zone ke roop mein mark kiya gaya hai. Company ne haal hee mein achhe Q2 ke numbers post kiye hain. Stock vartamaan mein 12.6 ke PE multiple par kaarobaar kar raha hai jabki industry ka average lagbhag 32 hai. Yah koee bhavishyavaanee nahin balki sambhaavit Wave count hai. Yah trade lene ya invest karne ki bhi salaah nahi hai. Kripya apana vishleshan svayan karen.
NSE:NATCOPHARMLong
by DhandhaPaani
Natco PharmaDate 12.09.2024 Natco Pharma Timeframe : Weekly Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natco Pharma cash from the operating activity was Rs 1,196.40 Cr. Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.06 , which is a strong indication for the company. EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was 109.10 % which is good for the company. Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 45.87 % which is a good sign for profitability. ROE: Natco Pharma have a healthy ROE of 25.38 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits. Regards, Ankur
NSE:NATCOPHARM
by AnkurSingh
Natco - Short term DARVAS technical trade Natco - Short term technical trade Fundamentals MCAP- 28000 Cr PE - 17.22 < Industry PE of 35.55 PEG Ratio is 1 Debt to Equity is 0.06 and ICR is 99 ROE is 26%, ROCE is 30% ( 5yr ROCE is 15%) Sales growth is 42%, 5yr Sales growth is 13% Profit Growth is 100%, 5yr Profit growth is 17% Promoter holding is 50% Latest results - excellent Technicals CMP - 1566 Bullish - Above EMA 9, 21,63, 200 on daily charts , RSI(14) is 75 Commentary Based on the Darvas box method, I expect Natco pharma to continue trading up. With CMP 1571, it has breached its own all time high with good volumes. As you can see the volumes yesterday was well over the 20 day moving average volume. I expect the trend to continue. The below targets are to ride this wave and catch as much upside as possible with little downside risk. Target : 1689 Stop Loss : 1420 (If already invested) , more conservative stop loss would be 2-3% below CMP Disclosure 1 - Invested Disclosure 2 - Not SEBI Registered Disclosure 3 - This is Not investment advice. Treat it as educational
NSE:NATCOPHARMLong
by harishnarayan2579
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1514 Next Resistance is at 1957 Support is at 1164 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:NATCOPHARMLong
by MandeepSinghKohli
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1090 Next Resistance is at 1514 Support is at 942 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:NATCOPHARMLong
by MandeepSinghKohli
NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG Investment type : short term (3-12 mnths) Cmp: 1025 R:R= 1:2 Pattern formed : Inverted head and shoulder Expected gains : 7% - 16.50% Bullish levels : - Level 1 : 1068.20 Level 2 : 111.6.10 Level 3 : 1193.30 SL: 932.20 this technical analysis is purely for education purpose only we did not recommend to invest as per our analysis for investment plz consult financial advisor . did you see how perfect inverted head and shoulder pattern was formed .
NSE:NATCOPHARMLong
by believe_in_your_dreams2517
6
Natco Pharma, the road ahead?Its been a journey of parallel channels for Natco Pharma share price and one believes that it will continue to tread within the broad confines of the longer term monthly channel Price has now found the resistance area of the channel which started from the lows of the covid (in blue). However, with the earnings on lenalidomide still some 15-18 months away from reaching peak levels, atleast in volume terms, by that time the street should hear expected positive news on some of the points listed below: - new successful para IV filings and launches from existing tentative or final approved list, - fixing the usfda cloud over kothur formulations plant, - traction on the much anticipated brownfield acquisition, - their CAR T investment growing into something tangible in value terms, - substantial increase in foreign subsidiary business - domestic formulation sales getting boost due to possible semalglutide launch - scaling up of crop health science business therefore looking at the hanging man on WCB I believe that whether for profit booking or geo political or general broader market sentiment it can correct in the immediate shorter term, however, the bullish thesis remains for the fundamental reasons enumerated above.. The first target from here seems to be around 2500 which can be plotted either by box breakout (from 2017 highs) or a rounding bottom (from 2021 highs) or simply the width of the blue parallel channel if and when it breaks out... The principle of polarity suggests that price may not close below the line plotted by taking the highs of 2017 and 2021 (the pink dotted line) this area should be our longer term stop loss and a time to revisit the bullish thesis.
NSE:NATCOPHARMLong
by Rocky_Chow
Welcome to the month of volatility for the Magic Pill February 2024 is the month of volatility and true to form even technical resistance lines are hovering above .. the final decision of the usfda over the kothur plant inspection will be out and the q3 expected blip in the results due to the accounting policy of the booking sales and profit share of gRevlimid drug .. Meanwhile the API plant in Manali, Chennai is back running post a brief halt in production due to flooding issues in the vicinity and the US lawsuit against the company has been dropped while the export oriented production units of the company must be busy manufacturing gRevlimid for the new calendar year at higher volumes than the previous year.. bottom line.. hold her steady!
NSE:NATCOPHARMLong
by Rocky_Chow
Time has come for Natco to repeat the cycleExplaining the current impasse in fibonacci terms: > In the previous upmove 0.618 was the resistance from which share price retreated despite blockbuster earnings coinciding with a slew of negative news.. > After finally exploding through 0.618 level, the next logical resistance level of 0.786 is the new barrier.... Once it overcomes this resistance it may travel all the way to the ATH level >Last May post Q1 results the party had started for Natco Pharma, the cycle may repeat this time around
NSE:NATCOPHARMLong
by Rocky_Chow
Slow and steady Natco getting ready for another hop, skip & jumpWhile the market is rife with speculation of specific stocks and sectors getting a boost due to possible budget discretionary impact I continue to focus on Natco Pharmas steady rise in price as it begins to start the catch up with its stellar business performance... One can see the bollinger band reducing now and the share price coiling up within a triangle like boundary... a successful breakout can lead to 1339 as a possible destination and that also opens up a flag pattern BO which can ultimately lead to 1500+ Its just my personal opinion of what the Q1 results may throw up if the same is positive... have kept a stop loss of close below 1120 technically speaking, from a trading perspective... fundamentally it merits a higher pecking order in the pharma stable but the market is what it is... no point arguing with it
NSE:NATCOPHARMLong
by Rocky_Chow
Natco pharma flying highNatco pharma can double from here with in few years. Sl below the trend line. Chart is self explanatory. Please follow the price action & take the trade as per your appetite. The information provided here is only for educational purpose. The information provided here is not intended to be any kind of financial advice, investment advice, and trading advice. Investment in stock market is very risky and trading stocks, options and other securities involve risk. The risk of loss in stock market can be substantial. Moreover, I am not a SEBI registered analyst, so before taking any decision or before investing in any Share consult your financial advisor and also do your analysis and research. Request your support and engagement by liking and commenting & follow to provide encouragement.
NSE:NATCOPHARMLong
by peacemaker202444